Published in Z Kardiol on June 01, 1981
[Comparison of results of daily blood pressure self-monitoring and general practice monitoring within the scope of a study assessing treatment of hypertension with quinapril]. Wien Med Wochenschr (1992) 1.38
Sunitinib in metastatic thymic carcinomas: laboratory findings and initial clinical experience. Br J Cancer (2010) 1.23
Chloroquine as a probe for antigen processing by accessory cells. Transplantation (1982) 1.11
Extremely-low-dose aspirin (1 mg per day) renders human platelets more sensitive to antiaggregation prostaglandins. N Engl J Med (1984) 1.05
A comparison of the effect of different bicycle helmet laws in 3 New York City suburbs. Am J Public Health (1999) 0.98
Karyotypic dissection of Hodgkin's disease cell lines reveals ectopic subtelomeres and ribosomal DNA at sites of multiple jumping translocations and genomic amplification. Leukemia (2000) 0.97
[Segmental blood supply measurement in the upper extremities]. Wien Z Inn Med (1971) 0.96
Immigrant women family caregivers in Canada: implications for policies and programmes in health and social sectors. Health Soc Care Community (2006) 0.94
Successful eradication of Helicobacter pylori as determined by ((13))C-urea breath test does not alter fibrinogen and acute phase response markers. Thromb Res (2000) 0.93
The absorption and scattering of light in bovine and human dental enamel. Calcif Tissue Res (1975) 0.92
Three-dimensional ultrasound in obstetrics and gynaecology: technique, possibilities and limitations. Hum Reprod (1994) 0.89
Predictors of falls in elderly people during rehabilitation after hip fracture--who is at risk of a second one? Z Gerontol Geriatr (2003) 0.89
Epoprostenol and platelet deposition in atherosclerosis. Lancet (1984) 0.88
MRI-based pre-planning in patients with cervical cancer treated with three-dimensional brachytherapy. Br J Radiol (2011) 0.88
The decay accelerating factor mutation I197V found in hemolytic uraemic syndrome does not impair complement regulation. Mol Immunol (2007) 0.87
Can guidelines improve referral to elective surgical specialties for adults? A systematic review. Qual Saf Health Care (2010) 0.86
Effect of prostaglandin E1 on deposition of autologous labelled platelets onto human atherosclerotic lesions in vivo. Postgrad Med J (1987) 0.86
Effects of age and smoking on the pharmacokinetics of pindolol and propranolol. Br J Clin Pharmacol (1982) 0.83
Decreased stability of prostacyclin after acute myocardial infarction. Lancet (1987) 0.82
Luminescence quantum yields of sound and carious dental enamel. Calcif Tissue Res (1977) 0.82
Closure or nonclosure of the visceral peritoneum at cesarean delivery. Am J Obstet Gynecol (1996) 0.82
Growth deficient fetuses with absent or reversed umbilical artery end-diastolic flow are metabolically compromised. Early Hum Dev (1995) 0.81
Direct volumetric flow cytometric quantitation of CD34+ stem and progenitor cells. Transfus Med (2012) 0.81
Antimitotic actions of vasodilatory prostaglandins--clinical aspects. Agents Actions Suppl (1997) 0.80
An evaluation of the Filshie clip for postpartum sterilization in Austria. Contraception (1996) 0.80
Three-dimensional ultrasound in prenatal diagnosis of skeletal dysplasia. Prenat Diagn (1995) 0.80
Effect of epoprostenol on platelet deposition on synthetic artery grafts. Lancet (1984) 0.80
[Beta-blockader, pindolol, in the therapy of angina pectoris; a report on a multicentric controlled study]. Wien Med Wochenschr (1979) 0.79
[Observations on vein tonus and vein capacity in cardiac insufficiency]. Verh Dtsch Ges Kreislaufforsch (1968) 0.79
Beneficial effect of long-term PGE1-treatment in left ventricular heart failure. Prostaglandins Leukot Essent Fatty Acids (1989) 0.79
Cases of contact dermatitis caused by ultrasonographic gel. J Ultrasound Med (1998) 0.79
Prostacyclin synthesis stimulating plasma factor in patients with peripheral vascular disease. Prostaglandins Leukot Med (1987) 0.79
Cystic lymphangioma of stomach and jejunum: report of one case. J Surg Oncol (1981) 0.79
Participation of immigrant women family caregivers in qualitative research. West J Nurs Res (2001) 0.79
Synergistic effect of prostaglandin E1 and isosorbide dinitrate in peripheral vascular disease. Lancet (1990) 0.79
The prostacyclin synthesis stimulating plasma factor is unchanged during acute angina pectoris. Prostaglandins Leukot Med (1985) 0.79
Evaluation of isradipine and captopril alone or in combination for the treatment of hypertension. J Cardiovasc Pharmacol (1991) 0.79
Re: Gender incidence of intracytoplasmic morphologically selected sperm injection-derived embryos: a prospective randomized study. Reprod Biomed Online (2012) 0.79
20 mg aspirin daily--evidence for a clinical future of this extremely low-dose in arterial disease? Vasa (1988) 0.78
[Defects in the prostaglandin system. V. Inherited (?) disorder of prostacyclin degradation in the plasma (Wien-Döbling defect)]. Wien Klin Wochenschr (1985) 0.78
Beneficial effect of prostaglandin I2 on smooth muscle cell proliferation. Prog Clin Biol Res (1987) 0.78
Platelet sensitivity to antiaggregatory prostaglandins (PGE1,D2,I2) in patients with peripheral vascular disease. Am J Hematol (1985) 0.77
Studies on the dehydrogenation of proline and hydroxyproline in animal tissue. Enzymologia (1970) 0.77
A double blind placebo controlled trial of intravenous prostacyclin (PGI2) in 108 patients with ischaemic peripheral vascular disease. Prostaglandins (1990) 0.77
Hypertension and beneficial treatment with beta-blocking agents does not change the platelet sensitivity to the antiaggregatory prostaglandins. Prostaglandins Leukot Med (1982) 0.77
Effects of bopindolol on platelet function in hypertension at rest and during exercise. Prostaglandins Leukot Essent Fatty Acids (1990) 0.77
Prostacyclin (PGI2) contracts normal and varicose human saphenous veins. Vasa (1984) 0.77
Platelet response during prostaglandin E1-therapy in patients with non-insulin-dependent diabetes mellitus. Thromb Res (1997) 0.77
Ovarian stimulation in ART - Unwinding pressing issues. Minerva Ginecol (2015) 0.77
Risk assessment after hip fracture: check the "healthy" leg! Z Gerontol Geriatr (2011) 0.76
Pathomechanisms of atherosclerosis beneficially affected by prostaglandin E1 (PGE1)--an update. Vasa Suppl (1989) 0.76
Modification of platelet function by isosorbide dinitrate in patients with coronary artery disease. Thromb Res (1992) 0.76
Jogging causes a significant increase in platelet sensitivity to prostacyclin. Int J Sports Med (1986) 0.76
New approaches towards ex vivo and in vivo gene therapy. Cells Tissues Organs (2000) 0.76
Enhanced in-vitro platelet aggregability during postprandial hyperlipidaemia. Lancet (1993) 0.76
Radiolabelling autologous monocytes with 111-indium-oxine for reinjection in patients with atherosclerosis. Prog Clin Biol Res (1990) 0.76
Postprandial hyperlipemia does not inhibit platelet aggregation. Prostaglandins Leukot Essent Fatty Acids (1992) 0.76
Platelet half-life, plasma thromboxane B2 and circulating endothelial-cells in peripheral vascular disease. Angiology (1986) 0.76
Indication for antihypertensive treatment: superiority of ambulatory vs casual blood pressure measurement. Blood Press Suppl (1994) 0.76
Association of HELLP syndrome with autoimmune antibodies and glucose intolerance. Diabetes Care (2000) 0.76
The effect of intrinsic sympathomimetic activity of beta-adrenoceptor blockers on circadian heart rate. Br J Clin Pharmacol (1982) 0.75
Arterial subdural hematoma. Surg Neurol (1997) 0.75
Detection of aneurysms by gamma-camera imaging after injection of autologous labelled platelets. Lancet (1984) 0.75
Development of optimal infusion regimens for epoprostenol using radio labelled platelet uptake over atherosclerotic lesions in man. Br J Clin Pharmacol (1987) 0.75
Stabilization of endothelial lining and decrease in circulating endothelial cells--one mechanism underlying the clinical action of PGE1? Br J Clin Pharmacol (1988) 0.75
Prostaglandin I2 and the nitric oxide donor molsidomine have synergistic effects on thromboresistance in man. Br J Clin Pharmacol (1992) 0.75
Calcium antagonists and hypercalcaemia. Lancet (1991) 0.75
[Postural hypotension: pathophysiology and clinical features (author's transl)]. Wien Klin Wochenschr (1977) 0.75
Influence of smoking and age on pharmacokinetics of beta-receptor blockers. Gerontology (1982) 0.75
[Pindolol as an antihypertensive agent]. Fortschr Med (1977) 0.75
[Influence of physical training on resting and exercise haemodynamics in patients after acute myocardial infarction (author's transl)]. Wien Klin Wochenschr (1981) 0.75
Prostaglandin I2 reduces activation of human arterial smooth muscle cells in-vivo. Prostaglandins (1987) 0.75
[Contribution of long-term ECG monitoring in analysing cardiac arrhythmias (author's transl)]. Wien Klin Wochenschr (1981) 0.75
[The question of early failure with early mobilised patients with myocardial infarction (author's transl)]. MMW Munch Med Wochenschr (1974) 0.75
[Comparison of 24-hour long-term electrocardiogram and exercise testing in the detection of ventricular arrhythmias (author's transl)]. Z Kardiol (1982) 0.75
Monitoring of in-vivo platelet deposition in patients with peripheral vascular disease after different doses of prostaglandin I2 (PGI2). Prog Clin Biol Res (1987) 0.75
[Echocardiographic diagnosis of subpulmonic obstruction in hypertrophic cardiomyopathy (a case report) (author's transl)]. Z Kardiol (1979) 0.75
[Early orthostatic regulatory disorders of blood circulation]. Wien Z Inn Med (1970) 0.75
[Value of quantitative determination of circulation in peripheral arterial occlusion diseases]. Wien Z Inn Med (1966) 0.75
Prostaglandin I2 during radiolabelling improves recovery, but does not change platelet half-life and platelet uptake over active human lesion sites. Prostaglandins (1987) 0.75
[Early mobilization of patients following myocardial infarct]. Wien Klin Wochenschr Suppl (1974) 0.75
[Side effects of roentgen contrast media injections with and without antihistaminics]. Wien Med Wochenschr (1975) 0.75
[Coronary infarct and peripheral blood flow]. Med Welt (1969) 0.75
[Influence of carbon tetrachloride poisoning on structure-bound enzymes of rat liver mitochondria]. Wien Klin Wochenschr (1972) 0.75
Clinical benefit and prolongation of platelet half-life induced by CG 4203, a stable PGI2-analogue. Prog Clin Biol Res (1987) 0.75
[The influence of electrode pressure upon the rheogram (author's transl)]. Wien Klin Wochenschr (1974) 0.75
[Value of the detection of arteriosclerotic lesions with labeled autologous thrombocytes]. Acta Med Austriaca (1982) 0.75
[Optimized sequential pacing of atrium and ventricle (author's transl]. Wien Med Wochenschr (1981) 0.75
[Immediate internal complications in permanently implanted electric pacemakers]. Wien Z Inn Med (1967) 0.75
[Influence of the venous wall--platelet interaction by dihydroergotamine (author's transl)]. Wien Klin Wochenschr (1981) 0.75
Studies on pharmacokinetics, platelet function and fibrinolytic activity under various prostaglandin E1 infusion regimens. Prog Clin Biol Res (1987) 0.75
[A new method for determination of the venous capacity]. Zentralbl Phlebol (1967) 0.75
[Modification of the repair phase in myocardial infarct through partial parenteral feeding. Preliminary report]. Wien Med Wochenschr (1977) 0.75
[The effect of tissue resistance on rheography]. Acta Med Austriaca (1976) 0.75
Venous tone in correlation to position in normal case and in patients with phlebothrombosis. Angiology (1970) 0.75